Kange Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KGNR research report →
Company
Kange Corp. focuses on developing and marketing mobile software product as mobile applications for end users. It intends to provide technology and wholistic technology-based health treatments for various mental health conditions, such as autism, dementia, and Alzheimer's, as well as PTSD.
- CEO
- Arthur Malone Jr.
- IPO
- 2015
- HQ
- Studio City, CA, US
Price Chart
Valuation
- Market Cap
- $199.15M
- P/E
- -211.62
- P/S
- -24893906.38
- P/B
- -189.25
- EV/EBITDA
- 0.00
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 13836262.50%
- ROE
- 248.01%
- ROIC
- 0.00%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-85,697 · 37.45%
- EPS
- $-0.00 · 33.33%
- Op Income
- $0
- FCF YoY
- 5.88%
Performance & Tape
- 52W High
- $2.25
- 52W Low
- $0.07
- 50D MA
- $1.97
- 200D MA
- $1.47
- Beta
- -0.80
- Avg Volume
- 9
Get TickerSpark's AI analysis on KGNR
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our KGNR Coverage
We haven't published any research on KGNR yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KGNR Report →